| Literature DB >> 23986357 |
P Vijaya Babu1, Soumita Mukherjee, Girdhar Singh Deora, Keerthana Sarma Chennubhotla, Raghavender Medisetti, Swapna Yellanki, Pushkar Kulkarni, Shivashankar Sripelly, Kishore V L Parsa, Kiranam Chatti, K Mukkanti, Manojit Pal.
Abstract
A series of 1,3-disubstituted pyrrolo[2,3-b]quinoxalines has been designed for the potential inhibition of PDE4 without inhibiting luciferase. A ligand/PTC (phase transfer catalyst) free intramolecular Heck cyclization strategy was used to prepare these compounds, some of which showed significant inhibition of PDE4B (IC50≈ 5-14 μM) and growth inhibition of oral cancer cells (CAL 27) but not inhibition of luciferase in vitro. They also showed acceptable safety profiles but no apoptosis in zebrafish embryos.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23986357 DOI: 10.1039/c3ob41504j
Source DB: PubMed Journal: Org Biomol Chem ISSN: 1477-0520 Impact factor: 3.876